Sentences with phrase «pioglitazone in»

Not exact matches

Pioglitazone prevents hypertension and reduces oxidative stress in diet - induced obesity.

Pills to control blood sugar in people who have diabetes — like Avandia (rosiglitazone) or Actos (pioglitazone)-- make it harder to get sodium out of the body, which leads to swelling.

Both the Winn Feline Foundation and the Morris Animal Foundation currently fund studies in Illinois to see if the human anti-diabetic drug, pioglitazone, might help control (or perhaps, even prevent) the progression of diabetes in cats as it apparently does in humans (ref).

In Re: ACTOS (Pioglitazone) Products Liability Litigation, MDL No. 2299 (United States District Court, Western District of Louisiana):

The Actos Lawsuit Actos (pioglitazone) is a single - ingredient drug used to improve blood sugar control in diabetics.

He currently serves as co-lead counsel in the In re: Gadolinium Based Contrast Agent Litigation, which is pending in the U.S. District Court for the Northern District of Ohio; the Plaintiff's Executive Committee in the In re: Abilify Products Liability Litigation pending in the U.S. District Court for the Northern District of Florida; the Plaintiff's Executive Committee in the In re: Benicar Products Liability Litigation pending in the U.S. District Court for the District of New Jersey; the Plaintiff's Steering Committee in the In re: Actos (Pioglitazone) Products Liability Litigation pending in the U.S. District Court for the Western District of Louisiana; and the Plaintiff's Steering Committee in the In re: Fresenius Granuflo / Naturalyte Dialysate Products Liability Litigation pending in the U.S. District Court for the District of Massachusettin the In re: Gadolinium Based Contrast Agent Litigation, which is pending in the U.S. District Court for the Northern District of Ohio; the Plaintiff's Executive Committee in the In re: Abilify Products Liability Litigation pending in the U.S. District Court for the Northern District of Florida; the Plaintiff's Executive Committee in the In re: Benicar Products Liability Litigation pending in the U.S. District Court for the District of New Jersey; the Plaintiff's Steering Committee in the In re: Actos (Pioglitazone) Products Liability Litigation pending in the U.S. District Court for the Western District of Louisiana; and the Plaintiff's Steering Committee in the In re: Fresenius Granuflo / Naturalyte Dialysate Products Liability Litigation pending in the U.S. District Court for the District of MassachusettIn re: Gadolinium Based Contrast Agent Litigation, which is pending in the U.S. District Court for the Northern District of Ohio; the Plaintiff's Executive Committee in the In re: Abilify Products Liability Litigation pending in the U.S. District Court for the Northern District of Florida; the Plaintiff's Executive Committee in the In re: Benicar Products Liability Litigation pending in the U.S. District Court for the District of New Jersey; the Plaintiff's Steering Committee in the In re: Actos (Pioglitazone) Products Liability Litigation pending in the U.S. District Court for the Western District of Louisiana; and the Plaintiff's Steering Committee in the In re: Fresenius Granuflo / Naturalyte Dialysate Products Liability Litigation pending in the U.S. District Court for the District of Massachusettin the U.S. District Court for the Northern District of Ohio; the Plaintiff's Executive Committee in the In re: Abilify Products Liability Litigation pending in the U.S. District Court for the Northern District of Florida; the Plaintiff's Executive Committee in the In re: Benicar Products Liability Litigation pending in the U.S. District Court for the District of New Jersey; the Plaintiff's Steering Committee in the In re: Actos (Pioglitazone) Products Liability Litigation pending in the U.S. District Court for the Western District of Louisiana; and the Plaintiff's Steering Committee in the In re: Fresenius Granuflo / Naturalyte Dialysate Products Liability Litigation pending in the U.S. District Court for the District of Massachusettin the In re: Abilify Products Liability Litigation pending in the U.S. District Court for the Northern District of Florida; the Plaintiff's Executive Committee in the In re: Benicar Products Liability Litigation pending in the U.S. District Court for the District of New Jersey; the Plaintiff's Steering Committee in the In re: Actos (Pioglitazone) Products Liability Litigation pending in the U.S. District Court for the Western District of Louisiana; and the Plaintiff's Steering Committee in the In re: Fresenius Granuflo / Naturalyte Dialysate Products Liability Litigation pending in the U.S. District Court for the District of MassachusettIn re: Abilify Products Liability Litigation pending in the U.S. District Court for the Northern District of Florida; the Plaintiff's Executive Committee in the In re: Benicar Products Liability Litigation pending in the U.S. District Court for the District of New Jersey; the Plaintiff's Steering Committee in the In re: Actos (Pioglitazone) Products Liability Litigation pending in the U.S. District Court for the Western District of Louisiana; and the Plaintiff's Steering Committee in the In re: Fresenius Granuflo / Naturalyte Dialysate Products Liability Litigation pending in the U.S. District Court for the District of Massachusettin the U.S. District Court for the Northern District of Florida; the Plaintiff's Executive Committee in the In re: Benicar Products Liability Litigation pending in the U.S. District Court for the District of New Jersey; the Plaintiff's Steering Committee in the In re: Actos (Pioglitazone) Products Liability Litigation pending in the U.S. District Court for the Western District of Louisiana; and the Plaintiff's Steering Committee in the In re: Fresenius Granuflo / Naturalyte Dialysate Products Liability Litigation pending in the U.S. District Court for the District of Massachusettin the In re: Benicar Products Liability Litigation pending in the U.S. District Court for the District of New Jersey; the Plaintiff's Steering Committee in the In re: Actos (Pioglitazone) Products Liability Litigation pending in the U.S. District Court for the Western District of Louisiana; and the Plaintiff's Steering Committee in the In re: Fresenius Granuflo / Naturalyte Dialysate Products Liability Litigation pending in the U.S. District Court for the District of MassachusettIn re: Benicar Products Liability Litigation pending in the U.S. District Court for the District of New Jersey; the Plaintiff's Steering Committee in the In re: Actos (Pioglitazone) Products Liability Litigation pending in the U.S. District Court for the Western District of Louisiana; and the Plaintiff's Steering Committee in the In re: Fresenius Granuflo / Naturalyte Dialysate Products Liability Litigation pending in the U.S. District Court for the District of Massachusettin the U.S. District Court for the District of New Jersey; the Plaintiff's Steering Committee in the In re: Actos (Pioglitazone) Products Liability Litigation pending in the U.S. District Court for the Western District of Louisiana; and the Plaintiff's Steering Committee in the In re: Fresenius Granuflo / Naturalyte Dialysate Products Liability Litigation pending in the U.S. District Court for the District of Massachusettin the In re: Actos (Pioglitazone) Products Liability Litigation pending in the U.S. District Court for the Western District of Louisiana; and the Plaintiff's Steering Committee in the In re: Fresenius Granuflo / Naturalyte Dialysate Products Liability Litigation pending in the U.S. District Court for the District of MassachusettIn re: Actos (Pioglitazone) Products Liability Litigation pending in the U.S. District Court for the Western District of Louisiana; and the Plaintiff's Steering Committee in the In re: Fresenius Granuflo / Naturalyte Dialysate Products Liability Litigation pending in the U.S. District Court for the District of Massachusettin the U.S. District Court for the Western District of Louisiana; and the Plaintiff's Steering Committee in the In re: Fresenius Granuflo / Naturalyte Dialysate Products Liability Litigation pending in the U.S. District Court for the District of Massachusettin the In re: Fresenius Granuflo / Naturalyte Dialysate Products Liability Litigation pending in the U.S. District Court for the District of MassachusettIn re: Fresenius Granuflo / Naturalyte Dialysate Products Liability Litigation pending in the U.S. District Court for the District of Massachusettin the U.S. District Court for the District of Massachusetts.

According to an article that appeared Consumer Reports on August 21, 2012, the FDA advises against using the generic form, Pioglitazone, or the brand name Actos because of the risks discussed in this blog.

Actos is still sold in the US even though last year the US Food and Drug Administration put out a safety warning that pioglitazone - Actos is the brand version - may increase the chances of bladder cancer when taken for more than a year.

Symptoms of Bladder Cancer: • Blood in the urine • Straining or pain during urination • Urinating often • Incontinence • Fatigue • Bone tenderness • Pain • Weight loss FDA Drug Safety Communication: Update to ongoing safety review of Actos (pioglitazone) and increased risk of bladder cancer, FDA, June 15, 2011 The use of pioglitazone and the risk of bladder cancer in people with type 2 diabetes: nested case - control study, British Medical Journal, May 31, 2012